Efficacy of Neorenal Forte for the Complete Elimination of Residual Fragments
ConditionUrolithiasis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorNeopharm Bulgaria Ltd.
About this trial
The purpose of this study is to evaluate the efficacy of a specialized formula of phytotherapeutic extracts (Neorenal Forte) aiding the complete elimination of residual fragments after fURS in adults.
Eligibility criteria
Qualifiers
Male or female 18 to 65 years of age.
The subject has signed informed consent approved by an Ethics Committee and agrees to the on-site study visits.
A stone confirmed by NCCT of kidney, ureter and urinary bladder for assessment of size, number, location and stone density, within 90 days of fURS.
Single or multiple kidney stones with total size of 10x10 mm to 15x10 mm.
Disqualifiers
Subjects with anatomical anomalies revealed by ultrasound - stenosis of the pyelo-ureteral junction, horseshoe kidney, kidney malrotation, calyceal diverticulum, and others.
Ureteral stenosis.
History of ipsilateral renal surgery.
Hydronephrosis.
Trial design
Treatments tested in this trial
- Neorenal Forte
- Placebo
Treatment groups
120 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov